Healthy Aging and Women’s Health at The Heart Of The Scientific Exchange Event

Mirabel, Canada, April 10, 2025 – Renowned scientists from around the world convened in Montreal last week for the 14th edition of Lallemand Health Solutions’ Scientific Exchange event. This gathering provided a dynamic platform for sharing innovative scientific discoveries.

SciX: An Open Discussion to Foster Innovation

The conference program featured insightful talks on a variety of subjects, including women’s health, infant health, nutrition, healthy aging, the gut microbiome, and the gut-brain axis. Poster presentations unveiled recent findings from both published and unpublished preclinical and clinical research, conducted in close collaboration with the Rosell® Institute for Microbiome and Probiotics and its proprietary probiotic strains. These insights sparked discussions and nurtured new partnerships.

Sylvie Binda, Vice President of Research and Development at Lallemand Health Solutions, expressed: “SciX is an internal conference that brings together international collaborators to discuss research, development, and results. This year, we delved deeply into the theme of healthy aging and explored how nutrition, the gut microbiome, and sleep quality are key to aging well. Aging is inevitable. It is a trajectory that we can positively influence by adopting preventive behaviors and good nutritional habits. It’s never too early to take actions that will impact the way we live a long, healthy life.”

Jérôme Panes, President and General Manager at Lallemand Health Solutions, summarized the week’s proceedings: “We are fortunate to collaborate with passionate and curious individuals who continually push the boundaries of science in documenting the microbiome and its various health implications. Their work has the potential to enhance the quality of life for people of all ages, from infants to seniors, worldwide. We extend our heartfelt thanks to all our valued partners.”

This edition featured Dr. Gaël Toubon, a young researcher from Chalmers University of Technology in Sweden and the recipient of the inaugural Rosell® Institute prize. Dr. Toubon presented promising research on the Gut Microbiota and its relation to Incident Type 2 Diabetes, based on a prospective cohort study conducted in Sweden.

If you would like to collaborate and develop a project with probiotics, please contact our team.

Advancing Human Health with Pioneering Probiotic Research

At the Rosell® Institute for Microbiome and Probiotics by Lallemand, we leverage cutting-edge technologies and innovative scientific approaches to research and develop probiotic strains for human health applications. We are the research center of Lallemand Health Solutions, a global leader in the probiotic industry, specializing in producing and marketing bacteria- and yeast-based supplements for human health, food applications, nutricosmetics, and contract development and manufacturing.

Media Contact
Marilou Luneau, Communications Manager, Lallemand Health Solutions
mluneau@lallemand.com

SciX 2025 – Conference Program

Women’s Health Session

Pascale Rondeau – O-SMOSE: Exploring the Perinatal Probiotics Transmission from Mother to Newborn

Benoît Fouchaq, PhD – Biofortis: Maximizing Success in Clinical Research: Key Factors for Valuable Results

Babies’ health Session

Lise Sanchez – Lallemand SAS, INRAE: Isolation and characterization of beneficial commensal bacteria from human newborn to counteract altered primocolonization

Heather Jaspan, MD PhD – Seattle Children’s Research Institute, University of Cape Town: BiFIID: Bifidobacterium infantis supplementation in the first month of life to improve immunity in infants born to mothers with HIV

Gut Health Session

Joseph Wang, PhD and Cedoljub Bundalovic-Torma, PhD – Nimble Science: Spatially and temporally precise capsule-based sampling of the small intestine: New insights from a growing clinical cohort and its prospective uses in observational and interventional studies

Gut-Brain Axis Session

Alex Parker, PhD – Université de Montréal, CHUM: Mechanisms underlying neuroprotection by Lacticaseibacillus rhamnosus HA-114

Riadh Hammami, PhD – University of Ottawa: Microbiome extracellular vesicles as mediators of gut-brain signaling

Gaël Toubon, PhD – Chalmers University of Technology – Rosell Prize Winner: Gut Microbiota and Incident Type 2 Diabetes: A Prospective Swedish Cohort Study

Joël Doré, PhD – INRAE: News from the “French Gut” project

Nutrition and Healthy Aging Session

Muriel Thomas, PhD – INRAE: Lacticaseibacillus casei CNCM-I5663: a new probiotic that preserves muscle mass in preclinical models and is compatible with cheese or specialised finger foods for the elderly

Sylvie Binda, PhD VP R&D – Lallemand Health Solutions:  Effect of a synbiotic on muscle health in older adults

Marcia Da Silva Pinto, PhD – Lallemand Bio-Ingredients: Science-Backed Wellness:
Veri-te™ Resveratrol for Women’s Health and Aging

Tiphaine Blanchard, Dr Vét – Lallemand SAS, École nationale vétérinaire Toulouse: Using canine models to study aging: comparative analysis and nutritional interventions to promote healthy aging

Alexandre Caron, PhD – Université Laval: Brain-Body Crosstalk in Metabolic Diseases: Implications for Healthy Aging

Charles Morin, PhD – Université Laval: The role of sleeping in healthy aging

Aurélien Baudot – Cryptobiotix: Investigating probiotics and prebiotics for healthy ageing – a SIFR technology case study

Women’s Health Session 2

Julien Tremblay, PhD – Consultant: A Randomized Study of Probiotic Supplementation and Vaginal Microbiota Changes During Menstruation